Fortis Healthcare soars as Singh bros resign from board

Gayathri Udyawar
/ Categories: Trending, Markets

The stock of Fortis Healthcare was trading higher by around 20 per cent in the early morning session on Friday.

Malvinder Singh, Executive Chairman and Dr. Shivinder Singh, Non-Executive Vice Chairman resigned from the directorships of the company, the company said in a regulatory filing. The company's board has decided to meet on February 13, to discuss the issue.

The Delhi High Court, on January 31, allowed Daiichi Sankyo to collect an arbitration award for Rs. 3,500-crore from Singh brothers, the former promoters of Ranbaxy Laboratories. The Japanese drugmaker Daiichi alleged that Singh brothers concealed crucial information while selling Ranbaxy in 2008. Daiichi had to plead guilty in the US to charges of falsifying data and selling adulterated medicines. The drugmaker had to pay Rs. 3,500 crore as penalty.

Earlier, the Supreme Court of India had also barred the Singh brothers from selling any of their assets in Fortis Healthcare.

The stock reacted positively to the news and at 9:40 hours, the stock of Fortis Healthcare was trading at Rs. 150.80 per share, up by Rs. 24.70 or 19.59 per cent on Friday.

Previous Article Index trend and stocks in action February 09, 2018
Next Article Five stocks with buying interest
Rate this article:
5.0

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR